Efficacy of intravenous iron therapy for pregnancy with iron deficiency anaemia
Not Applicable
- Registration Number
- CTRI/2009/091/001077
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Pregnant women 14-32 weeks of gestation
Hb <10.5gm% -> 7gm%
Exclusion Criteria
Women with preexisting illness- chronic renal disease, inflammatory bowel disease
suspected acute infection
Severe anemia requiring blood transfusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in blood parameters- Hb, reticlocyte response, Serm Ferritin<br>Clinical improvement if anyTimepoint: Reticulocyte response 14 days after starting therapy<br> Other parameters - 30 days after initiation of therapy and at 38 weeks of gestation / delivery
- Secondary Outcome Measures
Name Time Method Baby weight, Hb of Baby <br>Postnatal Hb of motherTimepoint: At and after delivery